tempted. The majority of strains were cultured from patients' blood, and a small number were cultured from stools, urine, and other specimens. The strains were maintained in rubber-stoppered, soft nutrient agar stabs, and typical colonies were selected on MacConkey agar plates before use.
Drugs. Freshly prepared solutions of the following drugs were used: CM (Parke, Davis & Co.), TC (Lederle Laboratories), streptomycin (SM; Banyu Seiyaku Co., Japan), sulfisomidine (SA; Daiichi Seiyaku Co., Japan), nalidixic acid (NA; Sterling-Winthrop Laboratories), AP (Beecham Research Laboratories), kanamycin (KM; Banyu Seiyaku Co., Japan), and a 1:20 mixture of trimethoprim (TMP; Burroughs Wellcome Co.) and sulfamethoxazole (SMZ; Roche Co.). TMP was dissolved in 0.1 N lactic acid, SMZ was dissolved in 0.1 N NaOH, and the other drugs were dissolved in appropriate solvents. They were further diluted before use (9, 15) .
Test for drug resistance. A plate dilution method was used throughout the study. Brain heart infusion (BiH) (pH 7.2; Difco) agar plates containing serial twofold concentrations of each drug were prepared as described by Williams and Ewing (20) . For (17) . Results were read after 24 h of incubation at 37°C, and the minimum inhibitory concentration (MIC) was defined as the lowest concentration of drugs that exhibited no growth, except SA and TMP-SMZ, for which the MIC was defined as the lowest concentration of drugs inhibiting confluent growth of large colonies (10) . Strains that grew in media containing 12.5 (Table 2 ). 11, 1977 on September 5, 2017 by guest http://aac.asm.org/ Downloaded from colonies of transconjugants were tested. To eliminate the possibility of transduction by phages, culture filtrates of donor strains were tested, and all of them were confirmed not to transfer the resistance to the recipient. The transfer frequency of CM, TC, SM, and SA resistance from S. typhi to E. coli was from 10-3.0 to 10-4.9 at 18 h of incubation at 37°C, and that of AP and KM resistance was from 10-5.3 to 10-6.7. Each selecting drug produced an almost similar degree of transfer frequency within a single donor strain, and the difference in frequency was marked by donor strains rather than by selecting drugs. With some randomly selected, quadruply resistant S. typhi, the transfer frequency was compared at two temperatures (Table 4) , and conjugation at 25°C was found to result in a much higher frequency than that at 370C. DISCUSSION Many reports have appeared on the emergence of S. typhi resistant to CM, and this resistance was frequently accompanied by resistance to other drugs (1, 3, 4, (12) (13) (14) 19) . However, in spite of the extensive use of CM for the treatment of typhoid fever for more than 15 years, CM-resistant strains were rare in Korea, as shown in this study and in other works (2, 5, 8) . The frequency of S. typhi multiply resistant to drugs was very low among our isolates, as compared with results obtained in the United (3, 4) , and sextuply resistant strains carried one more factor causing AP and KM resistance, as noted for strains in Mexico (14) . An R plasmid causing TC resistance was noted among strains isolated in Mexico, but none has been noted in Korean strains as yet. The complete patterns of transferable resistance of S. typhi will require further studies. Some strains were weakly resistant to three or fewer drugs and were proved not to carry transmissible R plasmids within the limits of our test and with the recipient strains used.
The multiple-drug resistance of S. typhi was transferred more easily at 25°C than at 37°C, as observed in S. typhimurium (18) , and this result suggests that receipt of multiple resistance by S. typhi would be more easily attained in defecated stools during warm seasons, when the ambient temperature is approximately 25°C, than in the intestinal canal. The transfer of multiple resistance to S. typhi from E. coli of various origins is being studied at different temperatures.
The occurrence of R plasmids in S. typhi is a warning to physicians, as well as to public health authorities, especially where the isolation of patients and the supervision of carriers are not well controlled. The presence of these strains also suggests the possibilities ofepidemics due to these organisms (14) and of a yearly increase in R plasmid strains (4) . Fortunately, the emergence of these strains was very infrequent when compared with that of E. coli and Shigella (11, 18) .
